Skye Bioscience Common Stock

Skye Bioscience (SKYE) currently reports a common stock of $35K as of June 2026. That compares with $31K in the prior-year period — up 13.4% year over year. Use the charts on this page to explore Skye Bioscience's common stock history and peer comparisons.

Skye Bioscience's common stock increased from $31K to $35K — a 13.4% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Skye Bioscience reported $35K in common stock as of June 2026. That compares with $31K in the prior-year period — up 13.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $35K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Skye Bioscience, and consider following SKYE for alerts when major investors trade the stock.